CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kai BioTech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kai BioTech Co Ltd
567, Baekje-daero, Deokjin-gu
Phone: +82 632195510p:+82 632195510 JEONJU, 54896  South Korea Ticker: 446600446600
Business Summary
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung and brain cancers as well as others. The Company is also engaged in the manufacture and sale of pheochromocytoma treatment, liver cancer treatment and other products.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yeong DeokKim 51
Internal Auditor Seon HuiKim 66
Director Jeong YilGwon 39
Other Non-Executive Director Gyeong SeokChae 46
Other Non-Executive Director Seok TaeYim 57

General Information
Number of Employees: 13 (As of 12/31/2023)
Outstanding Shares: 981,281 (As of 12/31/2023)
Stock Exchange: KON
Fax Number: +82 632195512


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024